The VAD Scheme versus Thalidomide plus VAD for Reduction of Vascular Endothelial Growth Factor in Multiple Myeloma: A Meta-Analysis

Figure 6

Forest plot comparing serum VEGF between initial and recurrent MM patients treated effectively with the T-VAD regimen [defined as complete remission (CR), very good partial remission (VGPR), or partial remission].